Metsera, Inc. (MTSR) Price Target Analysis
Wall Street analyst price targets, ratings consensus & upside potential · Updated May 1, 2026
Current Price
$70.50
Price Target
$55.50
Target Range
$54.00 — $57.00
Analyst Rating
Buy
Forward P/E—
Trailing P/E-34.7x
Forward PEG—
Implied Growth-14.4%
Median Target$55.50
Analyst Spread5.4%
Price Forecast (1 Year)
Last 12 months price action with 12-month analyst target path
Bear Case
$54
-23.4%
Consensus
$56
-21.3%
Bull Case
$57
-19.1%
MTSR Price Target Analysis
Updated May 8, 2026As of May 8, 2026, Metsera, Inc. (MTSR) has a Wall Street consensus price target of $55.50, based on estimates from 4 covering analysts. With the stock currently trading at $70.50, this represents a potential downside of -21.3%. The company has a market capitalization of $7.43B.
Analyst price targets range from a low of $54.00 to a high of $57.00, representing a 5% spread in expectations. The median target of $55.50 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 3 analysts rating the stock as a Buy or Strong Buy,1 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, MTSR trades at a trailing P/E of -34.7x. Analysts expect EPS to grow -14.4% over the next year.
Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Healthcare stocks.
Analyst Sentiment Comparison
Industry Peer AnalysisAvg Peer Upside+81.6%
Avg Forward P/E14.3x
Peers with Coverage10 / 10
| Company | Market Cap | Price | Target | Upside | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 VKTXViking Therapeutics, Inc. | $3.7B | $31.58 | $100.75 | +219.0% | Buy | — | 24 |
 TERNTerns Pharmaceuticals, Inc. | $4.6B | $52.95 | $55.56 | +4.9% | Buy | — | 16 |
 GPCRStructure Therapeutics Inc. | $2.3B | $39.15 | $114.75 | +193.1% | Buy | — | 14 |
 PEPGPepGen Inc. | $123M | $1.79 | $7.00 | +291.1% | Buy | — | 6 |
 NVONovo Nordisk A/S | $203.5B | $45.79 | $47.00 | +2.6% | Buy | 2.1x | 39 |
 LLYEli Lilly and Company | $921.2B | $974.96 | $1258.47 | +29.1% | Buy | 28.2x | 45 |
 AMGNAmgen Inc. | $177.6B | $329.06 | $350.76 | +6.6% | Buy | 14.7x | 38 |
 RYTMRhythm Pharmaceuticals, Inc. | $6.6B | $96.23 | $140.00 | +45.5% | Buy | — | 20 |
 CGONCG Oncology, Inc. Common stock | $5.8B | $69.18 | $79.86 | +15.4% | Buy | — | 9 |
 CVSCVS Health Corporation | $111.4B | $87.31 | $95.20 | +9.0% | Buy | 12.2x | 41 |
Upside Potential Comparison
PEPGVKTXGPCRRYTMLLYCGONCVSAMGNSee MTSR's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs MTSR Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare MTSR vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonMTSR — Frequently Asked Questions
Quick answers to the most common questions about buying MTSR stock.
What is the MTSR stock price target for 2026?
MTSR's consensus price target is $55.5, -21.3% below the current price of $70.5. The 4 analysts tracking MTSR see downside risk at present valuations.
Is MTSR a buy, sell, or hold?
MTSR has a consensus rating of "Buy" based on 4 Wall Street analysts. The rating breakdown is predominantly bullish, with 3 Buy/Strong Buy ratings. The consensus 12-month price target of $55.5 implies -21.3% downside from current levels.
Is MTSR stock overvalued or undervalued?
MTSR's current price is $70.5 with a consensus target of $55.5 (-21.3% implied move). Analyst estimates suggest the stock is overvalued at current levels.
How high can MTSR stock go?
The most bullish Wall Street analyst has a price target of $57 for MTSR, while the most conservative target is $54. The consensus of $55.5 represents the median expectation. These targets typically reflect 12-month expectations.
How many analysts cover MTSR stock?
MTSR is lightly followed, with 4 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 3 have Buy ratings, 1 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
What is the MTSR stock forecast?
The 12-month MTSR stock forecast based on 4 Wall Street analysts shows a consensus price target of $55.5, with estimates ranging from $54 (bear case) to $57 (bull case). The median consensus rating is "Buy".
Should I buy MTSR stock?
Analysts are cautious on MTSR, with 0 Sell ratings and a price target of $55.5 (-21.3% from current price). The "Buy" consensus suggests careful evaluation before buying. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
Why do MTSR price targets vary so much?
MTSR analyst price targets range from $54 to $57, a 5% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $55.5 consensus represents the middle ground.